Cepham Life Sciences

Cepham Life Sciences is a private, commercial-stage company serving the global life science research tools market. Its core business involves the manufacturing and distribution of a wide array of research products, including antibodies, ELISA kits, proteomics reagents, molecular biology tools, and lab equipment. The company appears to generate revenue through direct sales and a distributor network, targeting basic and applied research in areas like signal transduction, apoptosis, and protein analysis. Its value proposition centers on providing essential, quality-controlled reagents to accelerate scientific discovery.

Integrated capabilities in research reagent manufacturing, including antibody production/conjugation, protein biochemistry for proteomics, and assay development for ELISA and IHC. Offers contract manufacturing and custom formulation services.

Cepham operates in the highly fragmented and competitive life science research tools sector, competing against global giants (e.g., Thermo Fisher, Merck KGaA) and many niche players. Its differentiation likely hinges on specific product quality, customer service, pricing, and responsiveness in custom manufacturing rather than broad-scale dominance.